Forskning ved Københavns Universitet - Københavns Universitet

Forside

Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimer's disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimer's disease. / Jensen, Majbrit Myrup; Mikkelsen, Jens D.; Arvaniti, Maria; Pinborg, Lars Hageman; Thomsen, Morten Skøtt.

I: Neurobiology of Aging, Bind 36, Nr. 4, 01.04.2015, s. 1629-1638.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Jensen, MM, Mikkelsen, JD, Arvaniti, M, Pinborg, LH & Thomsen, MS 2015, 'Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimer's disease', Neurobiology of Aging, bind 36, nr. 4, s. 1629-1638. https://doi.org/10.1016/j.neurobiolaging.2015.01.001

APA

Jensen, M. M., Mikkelsen, J. D., Arvaniti, M., Pinborg, L. H., & Thomsen, M. S. (2015). Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimer's disease. Neurobiology of Aging, 36(4), 1629-1638. https://doi.org/10.1016/j.neurobiolaging.2015.01.001

Vancouver

Jensen MM, Mikkelsen JD, Arvaniti M, Pinborg LH, Thomsen MS. Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimer's disease. Neurobiology of Aging. 2015 apr 1;36(4):1629-1638. https://doi.org/10.1016/j.neurobiolaging.2015.01.001

Author

Jensen, Majbrit Myrup ; Mikkelsen, Jens D. ; Arvaniti, Maria ; Pinborg, Lars Hageman ; Thomsen, Morten Skøtt. / Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimer's disease. I: Neurobiology of Aging. 2015 ; Bind 36, Nr. 4. s. 1629-1638.

Bibtex

@article{5dce2b53fb254f4ca28d6675f28234b6,
title = "Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimer's disease",
abstract = "Alzheimer's disease (AD) is a neurodegenerative disorder involving impaired cholinergic neurotransmission and dysregulation of nicotinic acetylcholine receptors (nAChRs). Ly-6/neurotoxin (Lynx) proteins have been shown to modulate cognition and neural plasticity by binding to nAChR subtypes and modulating their function. Hence, changes in nAChR regulatory proteins such as Lynx proteins could underlie the dysregulation of nAChRs in AD. Using Western blotting, we detected bands corresponding to the Lynx proteins prostate stem cell antigen (PSCA) and Lypd6 in human cortex indicating that both proteins are present in the human brain. We further showed that PSCA forms stable complexes with the α4 nAChR subunit and decreases nicotine-induced extracellular-signal regulated kinase phosphorylation in PC12 cells. In addition, we analyzed protein levels of PSCA and Lypd6 in postmortem tissue of medial frontal gyrus from AD patients and found significantly increased PSCA levels (approximately 70{\%}). In contrast, no changes in Lypd6 levels were detected. In concordance with our findings in AD patients, PSCA levels were increased in the frontal cortex of triple transgenic mice with an AD-like pathology harboring human transgenes that cause both age-dependent β-amyloidosis and tauopathy, whereas Tg2576 mice, which display β-amyloidosis only, had unchanged PSCA levels compared to wild-type animals. These findings identify PSCA as a nAChR-binding protein in the human brain that is affected in AD, suggesting that PSCA-nAChR interactions may be involved in the cognitive dysfunction observed in AD.",
author = "Jensen, {Majbrit Myrup} and Mikkelsen, {Jens D.} and Maria Arvaniti and Pinborg, {Lars Hageman} and Thomsen, {Morten Sk{\o}tt}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.neurobiolaging.2015.01.001",
language = "English",
volume = "36",
pages = "1629--1638",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier",
number = "4",

}

RIS

TY - JOUR

T1 - Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimer's disease

AU - Jensen, Majbrit Myrup

AU - Mikkelsen, Jens D.

AU - Arvaniti, Maria

AU - Pinborg, Lars Hageman

AU - Thomsen, Morten Skøtt

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Alzheimer's disease (AD) is a neurodegenerative disorder involving impaired cholinergic neurotransmission and dysregulation of nicotinic acetylcholine receptors (nAChRs). Ly-6/neurotoxin (Lynx) proteins have been shown to modulate cognition and neural plasticity by binding to nAChR subtypes and modulating their function. Hence, changes in nAChR regulatory proteins such as Lynx proteins could underlie the dysregulation of nAChRs in AD. Using Western blotting, we detected bands corresponding to the Lynx proteins prostate stem cell antigen (PSCA) and Lypd6 in human cortex indicating that both proteins are present in the human brain. We further showed that PSCA forms stable complexes with the α4 nAChR subunit and decreases nicotine-induced extracellular-signal regulated kinase phosphorylation in PC12 cells. In addition, we analyzed protein levels of PSCA and Lypd6 in postmortem tissue of medial frontal gyrus from AD patients and found significantly increased PSCA levels (approximately 70%). In contrast, no changes in Lypd6 levels were detected. In concordance with our findings in AD patients, PSCA levels were increased in the frontal cortex of triple transgenic mice with an AD-like pathology harboring human transgenes that cause both age-dependent β-amyloidosis and tauopathy, whereas Tg2576 mice, which display β-amyloidosis only, had unchanged PSCA levels compared to wild-type animals. These findings identify PSCA as a nAChR-binding protein in the human brain that is affected in AD, suggesting that PSCA-nAChR interactions may be involved in the cognitive dysfunction observed in AD.

AB - Alzheimer's disease (AD) is a neurodegenerative disorder involving impaired cholinergic neurotransmission and dysregulation of nicotinic acetylcholine receptors (nAChRs). Ly-6/neurotoxin (Lynx) proteins have been shown to modulate cognition and neural plasticity by binding to nAChR subtypes and modulating their function. Hence, changes in nAChR regulatory proteins such as Lynx proteins could underlie the dysregulation of nAChRs in AD. Using Western blotting, we detected bands corresponding to the Lynx proteins prostate stem cell antigen (PSCA) and Lypd6 in human cortex indicating that both proteins are present in the human brain. We further showed that PSCA forms stable complexes with the α4 nAChR subunit and decreases nicotine-induced extracellular-signal regulated kinase phosphorylation in PC12 cells. In addition, we analyzed protein levels of PSCA and Lypd6 in postmortem tissue of medial frontal gyrus from AD patients and found significantly increased PSCA levels (approximately 70%). In contrast, no changes in Lypd6 levels were detected. In concordance with our findings in AD patients, PSCA levels were increased in the frontal cortex of triple transgenic mice with an AD-like pathology harboring human transgenes that cause both age-dependent β-amyloidosis and tauopathy, whereas Tg2576 mice, which display β-amyloidosis only, had unchanged PSCA levels compared to wild-type animals. These findings identify PSCA as a nAChR-binding protein in the human brain that is affected in AD, suggesting that PSCA-nAChR interactions may be involved in the cognitive dysfunction observed in AD.

U2 - 10.1016/j.neurobiolaging.2015.01.001

DO - 10.1016/j.neurobiolaging.2015.01.001

M3 - Journal article

C2 - 25680266

VL - 36

SP - 1629

EP - 1638

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 4

ER -

ID: 137154413